420 with CNW — What Employers Should Know About the Proposed Easing of Federal Cannabis Laws
Cannabis remains listed as a Schedule I substance under the Controlled Substances Act (CSA), a category reserved for drugs considered to have a high likelihood of misuse and no recognized medical purpose. That designation has shaped federal drug policy for decades and continues to influence workplace rules across the country. In 2023, the Biden administration backed a proposal to shift cannabis to a different category. Last year, President Donald Trump signed an order instructing the Justice Department to move forward with the formal rulemaking process to reclassify cannabis as a Schedule III substance. Moving marijuana into that group would signal federal recognition that it has accepted medical use in the United…
